Beta Bionics, Inc. · NASDAQ:BBNX

Farallon Capital Management, L.L.C.'s stake in Beta Bionics, Inc. fell to 1.30% (Schedule 13G/A)

Event Jun 30, 2026 · Filed Aug 13, 2026

Farallon Capital Management, L.L.C.'s stake in Beta Bionics, Inc. fell to 1.30%, 595,000 shares, as a passive investor on Jun 30, 2026. Filed Aug 13, 2026 (Schedule 13G/A).

Stake
1.30%
Shares
595,000
Intent
Passive
What changed
Fell below 5%
Filed together
28 holders

The filing in full

HolderStakeShares
Farallon Capital Management, L.L.C.1.30%595,000
Zone Healthcare Holdings, LLC0%0
Farallon Capital Partners, L.P.0%0
Farallon Capital Institutional Partners, L.P.0%0
Farallon Capital Institutional Partners II, L.P.0%0
Farallon Capital Institutional Partners III, L.P.0%0
Four Crossings Institutional Partners V, L.P.0%0
Farallon Capital Offshore Investors II, L.P.0%0
Farallon Capital (AM) Investors, L.P.0%0
Farallon Capital F5 Master I, L.P.0%0
Farallon Partners, L.L.C.0%0
Farallon Institutional (GP) V, L.L.C.0%0
Farallon F5 (GP), L.L.C.0%0
Dapice Joshua J.1.30%595,000
Dreyfuss, Philip D.1.30%595,000
Dunn Hannah E.1.30%595,000
Gehani, Varun N.1.30%595,000
Giauque, Nicolas1.30%595,000
Husen, Avner A.1.30%595,000
Kim, David T.1.30%595,000
Linn, Michael G.1.30%595,000
Luo Patrick (Cheng)1.30%595,000
Roberts, Jr., Thomas G.1.30%595,000
Saito Edric C.1.30%595,000
Short Daniel S.1.30%595,000
Spokes, Andrew J. M.1.30%595,000
Warren, John R.1.30%595,000
Wehrly, Mark C.1.30%595,000

Source

View original at SEC

Related